Deutsche Bank set a €140.00 ($162.79) price objective on Carl Zeiss Meditec (ETR:AFX) in a research report report published on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
A number of other analysts have also recently weighed in on the stock. Hauck & Aufhaeuser set a €110.00 ($127.91) price target on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Friday, January 31st. Independent Research set a €93.00 ($108.14) price target on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research note on Tuesday, December 10th. Kepler Capital Markets set a €80.00 ($93.02) price target on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research note on Monday, February 10th. HSBC set a €109.00 ($126.74) price target on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research note on Tuesday, December 10th. Finally, Nord/LB set a €132.00 ($153.49) price target on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of €111.14 ($129.24).
Shares of ETR:AFX opened at €108.90 ($126.63) on Tuesday. The stock has a market cap of $9.74 billion and a P/E ratio of 57.44. The firm has a fifty day moving average price of €115.83 and a 200 day moving average price of €106.77. The company has a debt-to-equity ratio of 4.06, a current ratio of 3.84 and a quick ratio of 3.01. Carl Zeiss Meditec has a 1-year low of €71.25 ($82.85) and a 1-year high of €122.10 ($141.98).
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
See Also: Analyst Ratings Trading
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.